gm-PBM treatment moderately reduced the latency to 48.80 ± 18.91 s, although this difference did not reach statistical significance when compared to the untreated AD group ( p = 0.17).
← all excerpts
Gut Microbiota-Targeted Photobiomodulation Ameliorates Alzheimer's Pathology via the Gut-Brain Axis: Comparable Efficacy to Transcranial Irradiation.
2
0.1700
0.1800
The sentences
a clear trendp = 0.18
The gm-PBM treatment group showed a clear trend toward improvement in entry frequency (3.8 ± 1.48 times); although the difference did not reach statistical significance versus the AD group ( p = 0.18), the numerical increase may hold biological relevance.